{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36530331", "DateRevised": {"Year": "2022", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.2c02446"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "7", "Issue": "49", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "13"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Use of Cheminformatics to Determine Potential Drug Interactions between Popular Barbadian Botanical Medicines and Antihypertensive Drugs.", "Pagination": {"StartPage": "44603", "EndPage": "44619", "MedlinePgn": "44603-44619"}, "Abstract": {"AbstractText": ["Barbados has a rich traditional use of medicinal plants, especially among the older population who may have a chronic noncommunicable disease. This study aims to identify possible drug-herb interactions between popular herbal remedies used to manage elevated blood pressure and conventional antihypertensive drugs. In this study, <i>in silico</i> molecular docking experiments with AutoDock Vina (Scripps Research Institute, La Jolla, CA), a part of Yasara Structure software, version 20.12.24, were used to screen 30 potential phytochemicals for drug interactions from 11 popular plants in Barbados that are used for high blood pressure and could influence the pharmacology of the most prescribed antihypertensive drugs in Barbados. Thiazide and thiazide-like diuretics, calcium channel blockers (CCBs), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin receptor blockers (ARBs) are the most prescribed antihypertensive drugs. Twenty-seven phytochemicals show dissociation constants (<i>K</i> <sub>d</sub>) < 10 \u03bcM with pharmacological drug targets. <i>Catharanthus roseus</i> (L.) G. Don, <i>Phyllanthus niruri</i> L., <i>Petroselinum crispum</i> (Mill.) Fuss, and <i>Lantana involucrata</i> L. contain various compounds that show high binding affinities in all experiments. Possible interactions could affect renal excretion (thiazide-like diuretics), CYP metabolism (CCBs), absorption (ACE-I), hepatic CYP, and phase II metabolism (ARB). Oleanolic acid shows high binding affinities to almost all protein targets. This study also reveals potential candidates for the drug targets: T-type Cav3.3 (psychiatric diseases), PEPT1/2 (influencing bioavailability), and BK channel (epilepsy). Twenty-seven of 30 phytochemicals from <i>C. roseus</i> (L.) G. Don (Madagascar periwinkle), <i>P. niruri</i> L. (Seed under leaf), <i>P. crispum</i> Mill. Fuss (Parsley), and <i>L. involucrata</i> L. (Rock sage) have potential binding affinities with pharmacological targets of frequently prescribed antihypertensive drugs in Barbados and are likely to cause drug interactions. Compounds that are similar to naringin (e.g., astragalin, rutin, and quercitrin) and compounds that bind to OATP1, PEPT1/2, and enzymes involved in the metabolism of CCBs may be clinically relevant for further research. There should be greater awareness of potential drug-herb interactions, and further <i>in vitro</i> and <i>in vivo</i> studies are needed to unravel the exact effects on the pharmacology."], "CopyrightInformation": "\u00a9 2022 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": ["0000-0001-9814-9126"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Utrecht University, David de Wied Building, Universiteitweg 99, 3584 CG Utrecht, The Netherlands."}], "LastName": "Evadgian", "ForeName": "Andraniek", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Preclinical and Health Sciences, Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, BB14000 St. Michael, Barbados."}], "LastName": "Bharatha", "ForeName": "Ambadasu", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Preclinical and Health Sciences, Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, BB14000 St. Michael, Barbados."}], "LastName": "Cohall", "ForeName": "Damian", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cohall D.Medicinal Plants of Barbados: For the Treatment of Communicable and Non-Communicable Diseases; The University of the West Indies Press, 2014."}, {"Citation": "Vujicic T.; Cohall D. Knowledge, Attitudes and Practices on the Use of Botanical Medicines in a Rural Caribbean Territory. Front. Pharmacol. 2021, 12, 1\u201320. 10.3389/fphar.2021.713855.", "ArticleIdList": ["10.3389/fphar.2021.713855", "PMC8579079", "34776949"]}, {"Citation": "Hoel R. W.; Giddings Connolly R. M.; Takahashi P. Y. Polypharmacy Management in Older Patients. Mayo Clin. Proc. 2021, 96, 242\u2013256. 10.1016/j.mayocp.2020.06.012.", "ArticleIdList": ["10.1016/j.mayocp.2020.06.012", "33413822"]}, {"Citation": "Bhadra R.; Ravakhah K.; Ghosh R. K. Herb-Drug Interaction: The Importance of Communicating with Primary Care Physicians. Aust. J. Med. Sci. 2015, 8, 315\u2013319. 10.4066/AMJ.2015.2479.", "ArticleIdList": ["10.4066/AMJ.2015.2479", "PMC4643608", "26576202"]}, {"Citation": "Tunstall-Pedoe H.; Kuulasmaa K.; Tolonen H.; Davidson M.; Mendis S.. et al.MONICA Monograph and Multimedia Sourcebook: World\u2019s Largest Study of Heart Disease, Stroke, Risk Factors, and Population Trends 1979-2002; World Health Organization, 2003."}, {"Citation": "Hennis A.; Wu S.; Nemesure L. M.; Leske M. C. Hypertension Prevalence, Control and Survivorship in an Afro-Caribbean Population. J. Hypertension 2002, 20, 2363\u20132369. 10.1097/00004872-200212000-00014.", "ArticleIdList": ["10.1097/00004872-200212000-00014", "12473859"]}, {"Citation": "Howitt C.; Hambleton I. R.; Rose A. M. C.; Hennis A.; Samuels T. A.; George K. S.; Unwin N. Social Distribution of Diabetes, Hypertension and Related Risk Factors in Barbados: A Cross-Sectional Study. BMJ Open 2015, 5, e00886910.1136/bmjopen-2015-008869.", "ArticleIdList": ["10.1136/bmjopen-2015-008869", "PMC4691788", "26685026"]}, {"Citation": "Caribbean Health Research Council . Managing Hypertension in Primary Care in the Caribbean; Caribbean Health Research Council: Trinidad and Tobago, 2007."}, {"Citation": "Adams O. P.; Carter O. A. Are Primary Care Practitioners in Barbados Following Hypertension Guidelines?\u2014A Chart Audit. BMC Res Notes 2010, 3, 236310.1186/1756-0500-3-316.", "ArticleIdList": ["10.1186/1756-0500-3-316", "PMC3006423", "21092153"]}, {"Citation": "Laurent S. Antihypertensive Drugs. Pharmacol. Res. 2017, 124, 116\u2013125. 10.1016/j.phrs.2017.07.026.", "ArticleIdList": ["10.1016/j.phrs.2017.07.026", "28780421"]}, {"Citation": "Gao Q.; Xu L.; Cai J. New Drug Targets for Hypertension: A Literature Review. Biochim. Biophys. Acta, Mol. Basis Dis. 2021, 1867, 16603710.1016/j.bbadis.2020.166037.", "ArticleIdList": ["10.1016/j.bbadis.2020.166037", "33309796"]}, {"Citation": "Rang H. P.; Ritter J. M.; Flower R. J.. Pharmacology, 8th ed.; Elsevier, 2016."}, {"Citation": "Samuels M. A.; Seifter J. L. Encephalopathies Caused by Electrolyte Disorders. Semin. Neurol. 2011, 31, 135\u2013138. 10.1055/s-0031-1277983.", "ArticleIdList": ["10.1055/s-0031-1277983", "21590618"]}, {"Citation": "Jim\u00e9nez J. V.; Carrillo-P\u00e9rez D. L.; Rosado-Canto R.; Garc\u00eda-Ju\u00e1rez I.; Torre A.; Kershenobich D.; Carrillo-Maravilla E. Electrolyte and Acid\u2013Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach. Dig. Dis. Sci. 2017, 62, 1855\u20131871. 10.1007/s10620-017-4597-8.", "ArticleIdList": ["10.1007/s10620-017-4597-8", "28501971"]}, {"Citation": "Welling G. Pharmacokinetics of the Thiazides Diuretics. Biopharm. Drug Dispos. 1986, 7, 501\u2013535.", "ArticleIdList": ["3828483"]}, {"Citation": "Opie L. H. Calcium Channel Antagonists: Part VI: Clinical Pharmacokinetics of First and Second-Generation Agents. Cardiovasc. Drugs Ther. 1989, 3, 482\u2013497. 10.1007/BF01865507.", "ArticleIdList": ["10.1007/BF01865507", "2488100"]}, {"Citation": "DrugBank, 2022. https://go.drugbank.com."}, {"Citation": "Nelson E. B.; Pool J. L.; Taylor A. A. Pharmacology of Angiotensin Converting Enzyme Inhibitors: A Review. Am. J. Med. 1986, 81, 13\u201318. 10.1016/0002-9343(86)90939-3.", "ArticleIdList": ["10.1016/0002-9343(86)90939-3", "3022580"]}, {"Citation": "Israili Z. H. Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension. J. Hum. Hypertens. 2000, 14, S73\u2013S86. 10.1038/sj.jhh.1000991.", "ArticleIdList": ["10.1038/sj.jhh.1000991", "10854085"]}, {"Citation": "Pandey P.; Singhal D.; Khan F.; Arif M. An in Silico Screening on Piper Nigrum, Syzygium Aromaticum and Zingiber Officinale Roscoe Derived Compounds against Sars-cov-2: A Drug Repurposing Approach. Biointerface Res. Appl. Chem. 2021, 11, 11122\u201311134. 10.33263/BRIAC114.1112211134.", "ArticleIdList": ["10.33263/BRIAC114.1112211134"]}, {"Citation": "Mooiman K. D.; Maas-Bakker R. F.; Moret E. E.; Beijnen J. H.; Schellens J. H. M.; Meijerman I. Milk Thistle\u2019s Active Components Silybin and Isosilybin: Novel Inhibitors of Pxr-Mediated Cyp3a4 Induction. Drug Metab. Dispos. 2013, 41, 1494\u20131504. 10.1124/dmd.113.050971.", "ArticleIdList": ["10.1124/dmd.113.050971", "23674609"]}, {"Citation": "Sardari S.; Shokrgozar M. A.; Ghavami G. Cheminformatics Based Selection and Cytotoxic Effects of Herbal Extracts. Toxicol. In Vitro 2009, 23, 1412\u20131421. 10.1016/j.tiv.2009.07.011.", "ArticleIdList": ["10.1016/j.tiv.2009.07.011", "19602433"]}, {"Citation": "Barbados Drug Service, 2022. https://www.gov.bb/Departments/drug-service."}, {"Citation": "Kim S.; Chen J.; Cheng T.; et al. PubChem in 2021: New Data Content and Improved Web Interfaces. Nucleic Acids Res. 2021, 49, 1388\u20131395. 10.1093/nar/gkaa971.", "ArticleIdList": ["10.1093/nar/gkaa971", "PMC7778930", "33151290"]}, {"Citation": "Krieger E.; Darden T.; Nabuurs S. B.; Finkelstein A.; V G. Making Optimal Use of Empirical Energy Functions: Force-Field Parameterization in Crystal Space. Proteins 2004, 57, 678\u2013683. 10.1002/prot.20251.", "ArticleIdList": ["10.1002/prot.20251", "15390263"]}, {"Citation": "Duan Y.; Wu C.; Chowdhury S.; Lee M. C.; Xiong G.; Zhang W.; Yang R.; Cieplak P.; Luo R.; Lee T.; et al. A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-Phase Quantum Mechanical Calculations. J. Comput. Chem. 2003, 24, 1999\u20132012. 10.1002/jcc.10349.", "ArticleIdList": ["10.1002/jcc.10349", "14531054"]}, {"Citation": "Wishart D. S.; Knox C.; Guo A. C.; Shrivastava S.; Hassanali M.; Stothard P.; Chang W. J. Drugbank: A Comprehensive Resource for in Silico Drug Discovery and Exploration. Nucleic Acids Res. 2006, 34, 668\u2013672. 10.1093/nar/gkj067.", "ArticleIdList": ["10.1093/nar/gkj067", "PMC1347430", "16381955"]}, {"Citation": "Bateman A.; Martin M. J.; Orchard S.; et al. UniProt: The Universal Protein Knowledgebase in 2021. Nucleic Acids Res. 2021, 49, 480\u2013489. 10.1093/nar/gkaa1100.", "ArticleIdList": ["10.1093/nar/gkaa1100", "PMC7778908", "33237286"]}, {"Citation": "Burley S. K.; Bhikadiya Charmi B. C.; et al. RCSB Protein Data Bank: Powerful New Tools for Exploring 3D Structures of Biological Macromolecules for Basic and Applied Research and Education in Fundamental Biology, Biomedicine, Biotechnology, Bioengineering and Energy Sciences. Nucleic Acids Res. 2021, 49, 437\u2013451. 10.1093/nar/gkaa1038.", "ArticleIdList": ["10.1093/nar/gkaa1038", "PMC7779003", "33211854"]}, {"Citation": "Waterhouse A.; Bertoni M.; Bienert S.; Studer G.; Tauriello G.; Gumienny R.; Heer F. T.; de Beer T.A.P.; Rempfer C.; Bordoli L.; Lepore R.; Schwede T. SWISS-MODEL: Homology Modelling of Protein Structures and Complexes. Nucleic Acids Res. 2018, 46, 296\u2013303. 10.1093/nar/gky427.", "ArticleIdList": ["10.1093/nar/gky427", "PMC6030848", "29788355"]}, {"Citation": "Studer G.; Rempfer C.; Waterhouse A. M.; Gumienny R.; Haas J.; Schwede T. QMEANDisCo\u2014Distance Constraints Applied on Model Quality Estimation. Bioinformatics 2014, 30, 505\u2013511. 10.1093/bioinformatics/btu457.", "ArticleIdList": ["10.1093/bioinformatics/btu457", "PMC7178391", "32048708"]}, {"Citation": "U.S. Department of Agriculture, Agricultural Research Service. Dr. Duke\u2019s Phytochemical and Ethnobotanical\nDatabases, 2021. https://phytochem.nal.usda.gov/."}, {"Citation": "Trott A. J.; Olson AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2010, 31, 455\u2013461. 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Zhou Y.; Xia X. M.; Lingle C. J. The Functionally Relevant Site for Paxilline Inhibition of BK Channels. Proc. Natl. Acad. Sci. U.S.A. 2020, 117, 1021\u20131026. 10.1073/pnas.1912623117.", "ArticleIdList": ["10.1073/pnas.1912623117", "PMC6969516", "31879339"]}, {"Citation": "Cox M. M.; Nelson D. L.. Lehninger Principles of Biochemistry, 7th ed.; W.H. Freeman & Co Ltd, 2017."}, {"Citation": "Overington J. P.; Al-Lazikani B.; Hopkins A. L. How Many Drug Targets Are There?. Nat. Rev. Drug Discovery 2006, 5, 993\u2013996. 10.1038/nrd2199.", "ArticleIdList": ["10.1038/nrd2199", "17139284"]}, {"Citation": "Howitt C.; Hambleton I. R.; Rose A. M. C.; Hennis A.; Samuels T. A.; George K. S.; Unwin N. Social Distribution of Diabetes, Hypertension and Related Risk Factors in Barbados: A Cross-Sectional Study. BMJ Open 2015, 5, e00886910.1136/bmjopen-2015-008869.", "ArticleIdList": ["10.1136/bmjopen-2015-008869", "PMC4691788", "26685026"]}, {"Citation": "Tao X.; MacKinnon R. Molecular Structures of the Human Slo1 K+ Channel in Complex with Beta4. eLife 2019, 8, e5140910.7554/eLife.51409.", "ArticleIdList": ["10.7554/eLife.51409", "PMC6934384", "31815672"]}, {"Citation": "Ellison D. H. Clinical Pharmacology in Diuretic Use. Clin. J. Am. Soc. Nephrol. 2019, 14, 1248\u20131257. 10.2215/CJN.09630818.", "ArticleIdList": ["10.2215/CJN.09630818", "PMC6682831", "30936153"]}, {"Citation": "U.S. Food and Drug Administration. Drug Development\nand Drug Interactions. Table of Substrates, Inhibitors and Inducers, 2022. https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers."}, {"Citation": "Striessnig J.; Koschak A. Exploring the Function and Pharmacotherapeutic Potential of Voltage-Gated Ca2+ Channels with Gene Knockout Models. Channels 2008, 2, 233\u2013251. 10.4161/chan.2.4.5847.", "ArticleIdList": ["10.4161/chan.2.4.5847", "18719397"]}, {"Citation": "Killer M.; Wald J.; Pieprzyk J.; Marlovits T. C.; L\u00f6w C. Structural Snapshots of Human PepT1 and PepT2 Reveal Mechanistic Insights into Substrate and Drug Transport across Epithelial Membranes. Sci. Adv. 2021, 7, eabk325910.1126/sciadv.abk3259.", "ArticleIdList": ["10.1126/sciadv.abk3259", "PMC8565842", "34730990"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "20"}, {"Year": "2022", "Month": "10", "Day": "21"}, {"Year": "2022", "Month": "12", "Day": "19", "Hour": "3", "Minute": "26"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36530331", "PMC9753521", "10.1021/acsomega.2c02446"]}}], "PubmedBookArticle": []}